Nevirapine and Mean cell volume increased - a phase IV clinical study of FDA data

Summary:

Mean cell volume increased is found among people who take Nevirapine, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Nevirapine and have Mean cell volume increased. It is created by eHealthMe based on reports of 11,611 people who have side effects when taking Nevirapine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 12, 2022

11,611 people reported to have side effects when taking Nevirapine.
Among them, 6 people (0.05%) have Mean cell volume increased.


What is Nevirapine?

Nevirapine has active ingredients of nevirapine. It is often used in hiv infection. eHealthMe is studying from 11,222 Nevirapine users for its effectiveness, alternative drugs and more.

What is Mean cell volume increased?

Mean cell volume increased (more than normal average red blood cell volume) is found to be associated with 770 drugs and 443 conditions by eHealthMe.

Number of Nevirapine and Mean cell volume increased reports submitted per year:

Could Nevirapine cause Mean cell volume increased?

Gender of people who have Mean cell volume increased when taking Nevirapine *:

  • female: 83.33 %
  • male: 16.67 %

Age of people who have Mean cell volume increased when taking Nevirapine *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 25 %
  • 40-49: 25 %
  • 50-59: 25 %
  • 60+: 25 %

Common drugs people take besides Nevirapine *:

  1. Lamivudine: 3 people, 50.00%
  2. Zerit: 2 people, 33.33%
  3. Videx: 2 people, 33.33%
  4. Augmentin: 2 people, 33.33%
  5. Ziagen: 2 people, 33.33%
  6. Zidovudine: 1 person, 16.67%
  7. Adenosine Phosphate: 1 person, 16.67%
  8. Amlodipine: 1 person, 16.67%
  9. Combivir: 1 person, 16.67%
  10. Didanosine: 1 person, 16.67%

Common side effects people have besides Mean cell volume increased *:

  1. Haemoglobin Decreased: 3 people, 50.00%
  2. Renal Failure Acute (rapid kidney dysfunction): 2 people, 33.33%
  3. Fever: 2 people, 33.33%
  4. Lactic Acidosis (low ph in body tissues): 2 people, 33.33%
  5. Malaise (a feeling of general discomfort or uneasiness): 2 people, 33.33%
  6. Blood Lactate Dehydrogenase Increased: 2 people, 33.33%
  7. Night Sweats (sweating in night): 2 people, 33.33%
  8. Pneumonia Pseudomonal (pseudomonas pneumonia is an infection caused by the microbe known as pseudomonas aeruginosa): 2 people, 33.33%
  9. Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 33.33%
  10. Pericardial Effusion (fluid around the heart): 2 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Nevirapine and have Mean cell volume increased?

Check whether Mean cell volume increased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Mean cell volume increased and when was it recovered:

Expand to all the drugs that have ingredients of nevirapine:

Alternative drugs to, pros and cons of Nevirapine:

Common Nevirapine side effects:

Browse all side effects of Nevirapine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Mean cell volume increased treatments and more:

COVID vaccines that are related to Mean cell volume increased:

Common drugs associated with Mean cell volume increased:

All the drugs that are associated with Mean cell volume increased:

Common conditions associated with Mean cell volume increased:

All the conditions that are associated with Mean cell volume increased:

How the study uses the data?

The study uses data from the FDA. It is based on nevirapine (the active ingredients of Nevirapine) and Nevirapine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: